Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial.

@article{Bellinghen2001RisperidoneIT,
  title={Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial.},
  author={M van Bellinghen and C De Troch},
  journal={Journal of child and adolescent psychopharmacology},
  year={2001},
  volume={11 1},
  pages={5-13}
}
Risperidone, an antipsychotic agent with combined serotonin (5-HT2A) and dopamine (D2) receptor-blocking properties, is associated with fewer extrapyramidal side effects in adults than conventional neuroleptics. Approved in 1993 for the treatment of schizophrenia, recent studies have highlighted its potential in other conditions, such as the management of behavioral disturbances. This phase II, double-blind, placebo-controlled study evaluated the efficacy and tolerability of risperidone in the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

Supplemental digital content 2

Haas M Quiroz, Ja Kushner, +37 authors I A Short
2016

Similar Papers

Loading similar papers…